drugset / Trial / NCT00741013
Quantifying Airway Inflammation With Radiologic Tests
Phase 0
Completed
22 enrolled
Washington University School of Medicine
Barnes-Jewish Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this randomized, double-blind, placebo controlled trial we used positron emission tomography to determine if lovastatin or recombinant human activated protein C exhibit anti-inflammatory effects in humans following intrabronchial installation of lipopolysaccharide (LPS or endotoxin).
Timeline
- Start
- 2007-03
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | 80 mg | Oral |
| Subject | recombinant human activated protein C | Protein / enzyme biologic | 24 ug/kg | Intravenous |